These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9272332)

  • 1. The United States research strategy on pertussis.
    La Montagne JR
    Dev Biol Stand; 1997; 89():25-8. PubMed ID: 9272332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom.
    Xing DK; Corbel MJ; Dobbelaer R; Knezevic I
    Vaccine; 2007 Apr; 25(15):2749-57. PubMed ID: 17368348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From pertussis to tuberculosis: what can be learned?
    Klein DL
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S302-8. PubMed ID: 10875805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acellular pertussis vaccines in Japan: past, present and future.
    Watanabe M; Nagai M
    Expert Rev Vaccines; 2005 Apr; 4(2):173-84. PubMed ID: 15889991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acellular pertussis vaccines: what lies ahead?
    Wiedermann BL
    Contemp Pediatr; 1995 Sep; 12(9):25-8, 30, 32 passim. PubMed ID: 10155576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can we control pertussis better? II. Old and new vaccines against pertussis].
    Gałazka A
    Przegl Epidemiol; 1997; 51(3):285-95. PubMed ID: 9411499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter acellular pertussis vaccine trial: a National Institutes of Health perspective.
    Klein DL
    Pediatrics; 1995 Sep; 96(3 Pt 2):547-8. PubMed ID: 7659474
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible options for new pertussis vaccines.
    Meade BD; Plotkin SA; Locht C
    J Infect Dis; 2014 Apr; 209 Suppl 1():S24-7. PubMed ID: 24626868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis: persistent pathogen, imperfect vaccines.
    Yeh SH
    Expert Rev Vaccines; 2003 Feb; 2(1):113-27. PubMed ID: 12901603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
    Wilson TR
    J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composition of acellular pertussis and combination vaccines: a general review.
    Jadhav SS; Gairola S
    Biologicals; 1999 Jun; 27(2):105-10. PubMed ID: 10600195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan.
    Kuno-Sakai H; Kimura M; Watanabe H
    Biologicals; 2004 Mar; 32(1):29-35. PubMed ID: 15026023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.
    Farizo KM; Burns DL; Finn TM; Gruber MF; Pratt RD
    J Infect Dis; 2014 Apr; 209 Suppl 1():S28-31. PubMed ID: 24626869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations.
    Gardner P
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S131-5. PubMed ID: 10447031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making vaccination policy: the experience with rubella.
    Parkman PD
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S140-6. PubMed ID: 10447033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health. The pertussis paradox.
    Allen A
    Science; 2013 Aug; 341(6145):454-5. PubMed ID: 23908204
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of pertussis and high expectations concerning vaccines].
    Wysocki J
    Przegl Epidemiol; 2004; 58 Suppl 1():39-43. PubMed ID: 15807156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescent and adult pertussis: disease burden and prevention.
    Edwards K; Freeman DM
    Curr Opin Pediatr; 2006 Feb; 18(1):77-80. PubMed ID: 16470167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.